Back to search

Article

Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort Study

2024-12-05

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Metformin is a pharmacological candidate to mitigate second-generation antipsychotic (SGA)-induced weight gain in patients with severe mental illnesses (SMI). <h4>Objective</h4> To evaluate the incidence, prevalence, and demographic patterns of metformin co-prescription among patients diagnosed with SMI initiating SGAs. To estimate the impact of co-prescription on weight. <h4>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4d453e15-9c39-582e-9fce-a050a22d5baa
DOI
10.1101/2024.12.03.24318407
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort StudyDOI 10.1101/2024.12.03.24318407
Select a neighboring publication to make it the new centre.